Page 445 - ILAE_Lectures_2015

94. GAILY E, GRANSTROM ML, HIILESMAA V, BARDY A (1988) Minor abnormalities in children of
mothers with epilepsy. J Paediatr 112, 520-529.

95. STEEGERS-THEUNISSEN RP, RENIER WO, BORM GF et al (1994) Factors influencing the risk of
abnormal pregnancy outcome in epileptic women: a multicentre prospective study. Epilepsy Res 18, 261-269.

96. TERAMO K, HIILESMAA V (1982) Pregnancy and fetal complications in epileptic pregnancies. In:
Epilepsy, Pregnancy and the Child. Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D (Eds.), Raven
Press, New York, USA, 53-59.

97. CHEN Y-H, CHIOU H-Y, LIN H-C, LIN H-L (2009) Effect of seizures during gestation on pregnancy
outcomes in women with epilepsy. Arch Neurol 66, 979-984.

98. KILIC D, PEDERSEN H, KJAERSGAARD MI et al (2014) Birth outcomes after prenatal exposure to
antiepileptic drugs – a population based study. Epilepsia 55(11), 1714-1721.

99. VEIBY G, DALTVEIT AK, ENGELSEN BA, GILHUS NE (2014) Fetal growth restriction and birth defects
with newer and older antiepileptic drugs during pregnancy. J Neurol 261, 579-588.

100. FARMEN AH, GRUNDT J, TOMSON T et al (2015) Intrauterine growth retardation in foetuses of women
with epilepsy. Seizure 28, 76-80.

101. SAMREN EB, VAN DUIJN CM, CHRISTIAENS L, HOFMAN A, LINDHOUT D (1999) Antiepileptic drug
regimes and major congenital abnormalities in the offspring. Ann Neurol 46, 739- 746.

102. DELGADO-ESCUTA AV, JANZ D: (1992) Consensus guidelines: preconception counselling, management,
and care of the pregnant woman with epilepsy. Neurology 42 (Suppl 5), 149-160.

103. JANZ D (1994) Are antiepileptic drugs harmful when taken during pregnancy? J Perinat Med 22, 367-377.
104. HOLMES LB, HARVEY EA, COULL BA et al (2001) The teratogenicity of anticonvulsant drugs. N Engl J

Med 344, 1132-1138.
105. FINNELL RH, DANSKY LV (1991) Parental epilepsy, anticonvulsant drugs, and reproductive outcome:

epidemiologic and experimental findings spanning three decades; 1: animal studies. Reprod Toxicol 5, 281-
299.
106. SAMREN EB, VAN DUIJIN C, KOCH S et al (1997) Maternal use of antiepileptic drugs and the risk of
major congenital malformations: a joint European prospective study of human teratogenesis associated with
maternal epilepsy. Epilepsia 38, 981-990.
107. OLAFSSON E, HALLGRIMSSON JT, HAUSER WA, LUDVIGSSON P, GUDMUNDSSON G (1998)
Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39, 887-892.
108. CUNNINGTON MC, WEIL JG, MESSENHEIMER JA, FERBER S, YERBY, M, TENNIS P (2011) Final
results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology 76, 1817-1823.
109. ARPINO C, BRESCIANINI S, ROBERT E et al (2000) Teratogenic effects of antiepileptic drugs: use of an
international database on malformations and drug exposure (MADRE). Epilepsia 41, 1436-1443.
110. ANDERSON RC (1976) Cardiac defects in children of mothers receiving anticonvulsant therapy during
pregnancy. J Pediatr 89, 318-319.
111. HIRSCHBERGER M, KLEINBERG F (1975) Maternal phenytoin ingestion and congenital abnormalities:
report of a case. Am J Dis Child 129, 984.
112. HANSON JW, SMITH DW (1975) The fetal hydantoin syndrome. J Pediatr 87, 285-290.
113. HERNANDEZ-DIAZ S, SMITH CR, SHEN A et al For the North American AED Pregnancy Registry; North
American AED (Antiepileptic Drug) Pregnancy Registry; Scientific Advisory Committee; North American
AED Pregnancy Registry (2012) Comparative safety of antiepileptic drugs during pregnancy. Neurology
78(21), 1692-1699.
114. DIAV-CITRON O, SHECHTMAN S, ARNON J, ORNOY A (2001) Is carbamazepine teratogenic? A
prospective controlled study of 210 pregnancies. Neurology 57, 321-324.
115. CAMPBELL E, KENNEDY F, RUSSELL A et al (2014) Malformation risks of antiepileptic drug
monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J
Neurol Neurosurg Psychiatry 85(9), 1029-1034.
116. GRANSTROM ML, HIILESMAAN VK (1992) Malformations and minor anomalies in children of epileptic
mothers: preliminary results of the prospective Helsinki study. In: Epilepsy, Pregnancy and the Child. Janz
D, Dam M, Richens A, Bossi L, Helge H and Schmidt D (Eds.), Raven Press, New York, USA, 251-258.
117. JENTINIK J, DOLK H, LOANE MA et al For the EUROCAT Antiepileptic Study Working Group (2010)
Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-
control study. BMJ 341, c6581.
118. KOCH S, LOSCHE G, JAGER-ROMAN E et al (1992) Major birth malformations and antiepileptic drugs.
Neurology 42(suppl 5):83-88.
119. DILIBERTI JH, FARNDON PA, DENNIS NR, CURRY CJR (1984) The fetal valproate syndrome. Am J
Med Genet 19, 473-481.
120. DUNCAN S, MERCHO S, LOPES-CENDES I et al (2001) Repeated neural tube defects and valproate
monotherapy suggest a pharmacogenetic abnormality. Epilepsia 42, 750-753.
121. MALM H, KAJANTIE E, KIVIRIKKO S (2002) Valproate embryopathy in three sets of siblings: Further
proof of hereditary susceptibility. Neurology 59, 630-633. Report of three families with recurring fetal
valproate syndrome.
122. FAIELLA A, WERNIG M, CONSALEZ GC (2000) A mouse model for valproate teratogenicity: parental
effects, homeotic transformations, and altered HOX expression. Hum Molecular Genet 9, 227-236.
123. NAU H (1985) Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional
injection regimen in the mouse. Toxicol Appl Pharmacol 80, 243-250.
124. VAJDA FJ, GRAHAM JE, HITCHCOCK AA et al (2010) Is lamotrigine a significant human teratogen?
Observations from the Australian Pregnancy Register. Seizure 19, 558-561.